Morton Brown Family Wealth’s CONMED CNMD Stock Holding History

Morton Brown Family Wealth’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15	Closed	-$1.56K	–	206
2023 Q1	$1.56K	Buy	+15	New	+$1.45K	﹤0.01%	218

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morton Brown Family Wealth's CNMD Position: Q2 2023 in Review

Morton Brown Family Wealth sold out of CONMED (CNMD) in Q2 2023, closing a stake of 15 shares — an estimated $1.56K sold.

Morton Brown Family Wealth first reported a position in CNMD in Q1 2023 and held it in 1 quarter. The position peaked at $1.56K in Q1 2023. 263 funds tracked by Wall St. Rank hold CNMD as of Q2 2023.

Morton Brown Family Wealth reported no remaining CONMED position as of Q2 2023 after selling out during the quarter.
Morton Brown Family Wealth sold 15 CONMED shares in Q2 2023, an estimated $1.56K.
Morton Brown Family Wealth first reported a position in CONMED in Q1 2023 and held it in 1 quarter.
Morton Brown Family Wealth's CONMED position peaked at $1.56K in Q1 2023.
263 funds tracked by Wall St. Rank held CONMED as of Q2 2023.

Based on Morton Brown Family Wealth's 13F filing for Q2 2023, filed 25 Jul 2023.